IL-10 enhances endothelial progenitor cell survival and function in ischemic myocardium, leading to improved left ventricular function and reduced remodeling in a mouse model of MI.
No takes yet. Share an insight, caveat, or question.
IL-10 may augment EPC therapy in experimental MI; leaves open translation to clinical practice.
Krishnamurthy et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: